Search For "pharma tariffs"
Trump declares 100% tariff on pharma; not applicable to generic medicines,
Updated : 5 months, 1 week ago IST
Chairperson of the topmost Pharmaceutical company, Pharmexcil, which earns 40 - 50 per cent of its total revenues from the American market also said, "Generic drugs are not impacted".
Read More
Indian pharma sector needs price hikes, site and IP transfers to tackle US
Updated : 5 months, 1 week ago IST
The Indian pharmaceutical industry requires price increases, site and intellectual property (IP) transfers to deal with the prevailing uncertainty in the sector amid US tariffs, according to a report by Systematix Research
Read More
Pharma businesses ready with contingency plans faced with US tariffs: Asso
Updated : 7 months, 1 week ago IST
Indian pharmaceutical manufacturers are preparing a two-pronged strategy to offset the impact of the soon-to-be-effective 25 per cent US tariff on Indian goods, which includes drug exports, with industry experts anticipating that the move could significantly raise medicine costs in the Ameri
Read More
Trump's latest 25% tariff will be applicable on all sectors, products from
Updated : 7 months, 1 week ago IST
The executive order signed by President Donald Trump on Thursday has imposed flat 25 per cent tariff on all goods from India, with no product-level exemptions, according to a report by the Global Trade Research Initiative (GTRI).
Read More
Trump's tariff move on India may backfire, say Pharma Industry Leaders
Updated : 7 months, 1 week ago IST
The Indian pharmaceutical industry has hit back strongly at the recent tariff announcement by U.S. President Donald Trump, calling it a move that could hurt the American healthcare system more than India's economy.
Read More
Any tariffs on pharma sector would be counterproductive for Americans: Woc
Updated : 11 months ago IST
Habil Khorakiwala, Chairman of pharma company Wockhardt on Friday indicated that any imposition of tariffs on pharma products by the US administration would be counterproductive for the Americans.
Read More
"Who's going to pay price to bring back manufacturing in US", asks Biocon
Updated : 11 months, 1 week ago IST
Siddharth Mittal, CEO and Managing Director of Biocon Limited, said on Friday asked who would pay the price to shift their shops in the US where pharma manufacturing costs are higher than in India and China.
Read More